Immunohistochemical results suggested that RGS16 could inhibit the apoptosis while promote the proliferation of CRC organoids, which further suggested that RGS16 potentially promote CRC progression (Fig. 6F, G). Here, RGS16 is linked to colorectal carcinoma.